SynCoreBio to Participate China BioMed Innovation and Investment Conference and Bio-partnering APAC on September 18-21
SynCore Biotechnology announced that the company will attend the [...]
SynCore Bio Signs Agreement with British Company Epipole to Distribute Eye Disease Diagnosis Fundus Cameras in Taiwan
SynCore Biotechnology Co. Ltd. (4192) signed an international contract [...]
SB05 PC is Approved to Conduct Phase III Clinical Trial for Pancreatic Cancer by ANSM
We are excited to announce that SynCore Biotechnology receives [...]
SynCore Bio SB04 Dry-AMD in Phase II/III trial
SB04 is an invasive treatment for dry Age-related Macular [...]
SynCore Biotechnology to Participate at the ChinaBio® Partnering Forum
SynCore Biotechnology announced that the company will attend the [...]
SynCore Biotechnology to Participate at the BIO-EUROPE SPRING – 12th Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the [...]
Syncore Biotechnology to Participate at the Biotech Showcase 2018 Conference
Syncore Biotechnology will attend the Biotech Showcase 2018 Conference [...]
SynCore Biotechnology to Participate at the BIO-Europe 2017 – 23rd Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the [...]
SynCore Biotechnology Receives Investigational New Drug (IND) Clearance of SB05 PC by the Taiwan Food and Drug Administration (TFDA) to Conduct a Phase III Clinical Trial for the Treatment of Metastatic Adenocarcinoma of the Pancreas
Investigational New Drug (IND) clearance from TFDA represents a [...]
SynCore Bio to present the Phase I study of SB01 at ASCO 2017
SynCore Biotechnology Co., Ltd. (SynCore) is selected to present [...]